Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I. Canales Ruiz
Baseline Total Metabolic Tumour Volume Is Highly Prognostic for Refractoriness to Immunochemotherapy in Dlbcl: An Analysis of the Phase 3 Goya Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Refractoriness to Immunochemotherapy in Follicular Lymphoma: Predictive Factors and Outcome
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Integration Between Metabolic Tumour Volume and Metabolic Heterogeneity Predicts Outcome of DLBCL Lymphoma Patients in the Sakk 38/07 Study Cohort
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Total Tumour Volume as a Prognostic Factor in Patients With Resectable Colorectal Cancer Liver Metastases
BJS open
Surgery
P2.12-15 Prognostic and Predictive Covariates in Limited-Stage Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
SRP Baseline Hydrogeologic Investigation, Phase 3
Cell of Origin Combined With CNS International Prognostic Index Improves Identification of DLBCL Patients With High CNS Relapse Risk After Initial Immunochemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Total 18f-Dopa PET Tumour Uptake Reflects Metabolic Endocrine Tumour Activity in Patients With a Carcinoid Tumour
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Achievement of VGPR to Induction Therapy Is an Important Prognostic Factor for Longer PFS in the IFM 2005-01 Trial
Blood
Biochemistry
Immunology
Cell Biology
Hematology
